HOW WE WORK
JAPAN READINESS
Assess strengths, IP,
evidence, and goals.
→
U.S. STRATEGY
Define market wedge, regulatory
path, and commercialization plan.
→
VALIDATION
Design clinical and evidence
plan, engage key experts
and pilot sites.
→
PARTNERSHIPS
Activate clinicians, customers,
and strategic partners.
→
CAPITAL
Achieve investor-ready
milestones and access
capital.
WHO WE WORK WITH
OUR PARTNERS
- Japanese startups and researchers
- Universities and innovation programs
- Government-supported commercialization programs
- Corporate and strategic partners
- U.S. clinicians, investors, and experts
FOCUSED SECTORS
- Medical devices
- Digital health
- Diagnostics
- Therapeutics
- Healthcare AI
- Deep-tech platforms